Item 404(a) of
Regulation S-K.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: December 7, 2007
|
|
TAPESTRY PHARMACEUTICALS, INC. |
|
|
|
|
|
|
|
By: |
/s/ Kai P. Larson |
|
|
|
Kai P. Larson |
|
|
|
Vice President, General Counsel |